Targeted Drug Delivery Systems for Eliminating Intracellular Bacteria

被引:18
作者
Feng, Wenli [1 ,2 ]
Chitto, Marco [2 ]
Moriarty, Thomas Fintan [2 ]
Li, Guofeng [1 ]
Wang, Xing [1 ]
机构
[1] Beijing Univ Chem Technol, State Key Lab Organ Inorgan Composites, Beijing Lab Biomed Mat, Beijing 100029, Peoples R China
[2] AO Res Inst Davos, CH-7270 Davos, Switzerland
基金
中国国家自然科学基金;
关键词
active targeting; cellular internalization; drug delivery system; intracellular bacterial infection; stimuli-responsive; ACID-BASED HYDROGELS; CHITOSAN NANOPARTICLES; ANTIBACTERIAL ACTIVITY; DUAL PH; ANTIBIOTICS; SALMONELLA; INFECTIONS; NANOCARRIERS; MACROPHAGES; CLEARANCE;
D O I
10.1002/mabi.202200311
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The intracellular survival of pathogenic bacteria requires a range of survival strategies and virulence factors. These infections are a significant clinical challenge, wherein treatment frequently fails because of poor antibiotic penetration, stability, and retention in host cells. Drug delivery systems (DDSs) are promising tools to overcome these shortcomings and enhance the efficacy of antibiotic therapy. In this review, the classification and the mechanisms of intracellular bacterial persistence are elaborated. Furthermore, the systematic design strategies applied to DDSs to eliminate intracellular bacteria are also described, and the strategies used for internalization, intracellular activation, bacterial targeting, and immune enhancement are highlighted. Finally, this overview provides guidance for constructing functionalized DDSs to effectively eliminate intracellular bacteria.
引用
收藏
页数:19
相关论文
共 172 条
  • [1] Alternatively activated macrophages; a double-edged sword in allergic asthma
    Abdelaziz, Mohamed Hamed
    Abdelwahab, Sayed F.
    Wan, Jie
    Cai, Wei
    Wang, Huixuan
    Cheng, Jianjun
    Kumar, Kesavan Dinesh
    Vasudevan, Aparna
    Sadek, Ahmed
    Su, Zhaoliang
    Wang, Shengjun
    Xu, Huaxi
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [2] Scaling of immune responses against intracellular bacterial infection
    Abdullah, Zeinab
    Knolle, Percy A.
    [J]. EMBO JOURNAL, 2014, 33 (20) : 2283 - 2294
  • [3] Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections
    Abed, Nadia
    Couvreur, Patrick
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (06) : 485 - 496
  • [4] Proteases and protease inhibitors in infectious diseases
    Agbowuro, Ayodeji A.
    Huston, Wilhelmina M.
    Gamble, Allan B.
    Tyndall, Joel D. A.
    [J]. MEDICINAL RESEARCH REVIEWS, 2018, 38 (04) : 1295 - 1331
  • [5] Extracellular Microvesicles as New Industrial Therapeutic Frontiers
    Agrahari, Vivek
    Agrahari, Vibhuti
    Burnouf, Pierre-Alain
    Chew, Chee Ho
    Burnouf, Thierry
    [J]. TRENDS IN BIOTECHNOLOGY, 2019, 37 (07) : 707 - 729
  • [6] Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis
    Anderson, GG
    Dodson, KW
    Hooton, TM
    Hultgren, SJ
    [J]. TRENDS IN MICROBIOLOGY, 2004, 12 (09) : 424 - 430
  • [7] Pneumococcal Encounter With the Blood-Brain Barrier Endothelium
    Anil, Anjali
    Banerjee, Anirban
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [8] Current and emerging therapies to combat persistent intracellular pathogens
    Arandjelovic, Philip
    Doerflinger, Marcel
    Pellegrini, Marc
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2019, 48 : 33 - 39
  • [9] Azad Abul K, 2014, J Cytol Mol Biol, V1
  • [10] Staphylococcus aureus Pathogenesis Secretion Systems, Adhesins, and Invasins
    Bartlett, Allison H.
    Hulten, Kristina G.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (09) : 860 - 861